R. Blumenthal

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

M. Lebwohl, A. Paller, E. Simpson, 2016, Journal of the American Academy of Dermatology.

Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.

J. Sukbuntherng, Dan Chen, R. Lal, 2012, Clinical therapeutics.

Free Communications 1 : Debate and Comments with the Expert Chairs CO 01 TOPICAL CORTICOSTEROID PHOBIA IN ATOPIC DERMATITIS : AN INTERNATIONAL VALIDATIONSTUDYOF THE TOPICOP SCORE

A. Lowe, A. Paller, E. Simpson, 2016 .

Clinical Evaluation of Xp19986 as a Potential Treatment for GERD: 25

J. Sukbuntherng, F. Huff, R. Lal, 2008 .

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.

J. Sukbuntherng, R. Lal, W. Luo, 2010, British journal of clinical pharmacology.